Cargando…
Mesenchymal Stem Cells May Ameliorate Nephrotic Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation-Case Report
INTRODUCTION: Because of their immunomodulatory and anti-inflammatory effects, mesenchymal stem cells (MSCs) have been considered as potential therapeutic agents for treating immune-related or autoimmune diseases, such as graft-versus-host disease (GVHD). Nephrotic syndrome (NS) after allogeneic hem...
Autores principales: | Zhang, Xin, Peng, Yanwen, Fan, Zhiping, Zhao, Ke, Chen, Xiaoyong, Lin, Ren, Sun, Jing, Wang, Guobao, Xiang, AndyPeng, Liu, Qifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557730/ https://www.ncbi.nlm.nih.gov/pubmed/28855905 http://dx.doi.org/10.3389/fimmu.2017.00962 |
Ejemplares similares
-
The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study
por: Chen, Shan, et al.
Publicado: (2019) -
The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation
por: Zhao, Ke, et al.
Publicado: (2016) -
Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation
por: Lin, Ren, et al.
Publicado: (2013) -
Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome
por: Zeng, Xiangzong, et al.
Publicado: (2021) -
Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
por: Xuan, Li, et al.
Publicado: (2021)